Related Experiment Video

Updated: Jun 20, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Polyomaviruses KI and WU in children with respiratory tract infection

Andreas Mueller1, Arne Simon, Julia Gillen

  • 1Department of Pediatrics, University of Bonn, Bonn, Germany. a.mueller@ukb.uni-bonn.de

Archives of Virology
|September 17, 2009
PubMed

Insights

KI polyomavirus (KIPyV) and WU polyomavirus (WUPyV) were rarely detected in German children with respiratory infections. Further studies are needed to determine the clinical relevance of these newly discovered polyomaviruses.

Area of Science:

  • Virology
  • Pediatrics
  • Infectious Diseases

Background:

  • KI polyomavirus (KIPyV) and WU polyomavirus (WUPyV) are recently identified human polyomaviruses.
  • These viruses have been associated with respiratory tract infections, necessitating further investigation into their prevalence and impact.

Observation:

  • A study screened 229 pediatric patients with acute respiratory tract infections in a German hospital.
  • Polymerase chain reaction (PCR) methods were used to detect KIPyV and WUPyV in nasopharyngeal aspirates and bronchoalveolar lavage samples.

Findings:

  • KIPyV was detected in 0.9% of patients, and WUPyV in 0.4%, totaling 1.3% positive cases.
  • No co-infections with other respiratory viruses were observed, but one immunocompromised patient had co-detection of CMV, EBV, and HHV-6.
  • The low detection rate suggests a limited role or specific conditions for KIPyV and WUPyV in pediatric respiratory infections.

Implications:

  • The clinical significance of KIPyV and WUPyV in pediatric respiratory infections remains uncertain due to their low prevalence in this cohort.
  • Further research is warranted to elucidate the pathogenic potential and clinical impact of these polyomaviruses in children.
  • This study highlights the need for ongoing surveillance and characterization of emerging viral pathogens in pediatric populations.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...